Nikcevich相关文献与解析，生知库 | 链接生命科学的每一步

Nguyen-Feng, Viann N; Frazier, Patricia A; Liu, Yuchen; Feddema, Erin; Wils, Benjamin; Nikcevich, Elizabeth; Stockness, Ali; Lim, Kelvin O; Hu, Amanda C; Butcher, Lisa; Misono, Stephanie

发表日期：2025

文献求助收藏

Improving Rural Clinical Trial Enrollment: Recommendations From the Rural Health Working Group of the Alliance Clinical Trials Network

改善农村临床试验入组率：联盟临床试验网络农村卫生工作组的建议

期刊:Journal of Clinical Oncology

影响因子:41.9

doi:10.1200/JCO.23.01667

Stout, Nicole L; Nikcevich, Daniel; Henderson, Tara O; Steen, Preston; Weiss, Matthias; Ades, Steven; Mlodozyniec, Tammie; Koffarnus, Amy; Barnick, Betsy; Paskett, Electra D

发表日期：2024

文献求助收藏

Induction versus no induction chemotherapy before neoadjuvant chemoradiotherapy and surgery in oesophageal adenocarcinoma: a multicentre randomised phase II trial (NCCTG N0849 [Alliance])

食管腺癌新辅助放化疗和手术前是否进行诱导化疗：一项多中心随机 II 期试验 (NCCTG N0849 [Alliance])

期刊:European Journal of Cancer

影响因子:7.1

doi:10.1016/j.ejca.2021.03.025

Yoon, Harry H; Ou, Fang-Shu; Soori, Gamini S; Shi, Qian; Wigle, Dennis A; Sticca, Robert P; Miller, Robert Clell; Leenstra, James L; Peller, Patrick J; Ginos, Brenda; Heying, Erica; Wu, Tsung-Teh; Drevyanko, Timothy F; Ko, Stephen; Mattar, Bassam Ibrahim; Nikcevich, Daniel A; Behrens, Robert J; Khalil, Maged F; Kim, George P; Alberts, Steven R

Patient-reported predictors of early treatment discontinuation: treatment-related symptoms and health-related quality of life among postmenopausal women with primary breast cancer randomized to anastrozole or exemestane on NCIC Clinical Trials Group (CCTG) MA.27 (E1Z03)

患者报告的早期治疗中断预测因素：在 NCIC 临床试验组 (CCTG) MA.27 (E1Z03) 中随机分配接受阿那曲唑或依西美坦治疗的绝经后原发性乳腺癌女性的治疗相关症状和健康相关生活质量

期刊:Breast Cancer Research and Treatment

影响因子:3

doi:10.1007/s10549-018-4713-2

Wagner, Lynne I; Zhao, Fengmin; Goss, Paul E; Chapman, Judith-Anne W; Shepherd, Lois E; Whelan, Timothy J; Mattar, Bassam I; Bufill, Jose A; Schultz, William C; LaFrancis, Irving E; Nagargoje, Gauri G; Vemuri, Radhakrishna; Nikcevich, Daniel A; Sledge, George W; Cella, David

Akt inhibitor MK-2206 in combination with bendamustine and rituximab in relapsed or refractory chronic lymphocytic leukemia: Results from the N1087 alliance study

Akt抑制剂MK-2206联合苯达莫司汀和利妥昔单抗治疗复发或难治性慢性淋巴细胞白血病：N1087联盟研究结果

期刊:American Journal of Hematology

影响因子:9.9

doi:10.1002/ajh.24762

Larsen, Jeremy T; Shanafelt, Tait D; Leis, Jose F; LaPlant, Betsy; Call, Tim; Pettinger, Adam; Hanson, Curtis; Erlichman, Charles; Habermann, Thomas Matthew; Reeder, Craig; Nikcevich, Daniel; Bowen, Deborah; Conte, Michael; Boysen, Justin; Secreto, Charla; Lesnick, Connie; Tschumper, Renee; Jelinek, Diane; Kay, Neil E; Ding, Wei

A randomized phase II trial comparing chemoimmunotherapy with or without bevacizumab in previously untreated patients with chronic lymphocytic leukemia.

一项随机 II 期试验比较了化疗免疫疗法联合或不联合贝伐单抗治疗既往未接受治疗的慢性淋巴细胞白血病患者的疗效

期刊:Oncotarget

影响因子:

doi:10.18632/oncotarget.13412

Kay Neil E, Strati Paolo, LaPlant Betsy R, Leis Jose F, Nikcevich Daniel, Call Timothy G, Pettinger Adam M, Lesnick Connie E, Hanson Curtis A, Shanafelt Tait D

The use of Ginkgo biloba for the prevention of chemotherapy-related cognitive dysfunction in women receiving adjuvant treatment for breast cancer, N00C9

银杏叶提取物用于预防接受乳腺癌辅助治疗的女性化疗相关认知功能障碍的研究，N00C9

期刊:Supportive Care in Cancer

影响因子:3

doi:10.1007/s00520-012-1647-9

Barton, Debra L; Burger, Kelli; Novotny, Paul J; Fitch, Tom R; Kohli, Sadhna; Soori, Gamini; Wilwerding, Mary Beth; Sloan, Jeff A; Kottschade, Lisa A; Rowland, Kendrith M Jr; Dakhil, Shaker R; Nikcevich, Daniel A; Loprinzi, Charles L

A Phase II trial of docetaxel and carboplatin administered every 2 weeks as preoperative therapy for stage II or III breast cancer: NCCTG study N0338

多西他赛和卡铂每两周给药一次，作为 II 期或 III 期乳腺癌术前治疗的 II 期试验：NCCTG 研究 N0338

期刊:American Journal of Clinical Oncology-Cancer Clinical Trials

影响因子:1.8

doi:10.1097/COC.0b013e318256f619

Roy, Vivek; Pockaj, Barbara A; Allred, Jacob B; Apsey, Heidi; Northfelt, Donald W; Nikcevich, Daniel; Mattar, Bassam; Perez, Edith A

Association of obesity with DNA mismatch repair status and clinical outcome in patients with stage II or III colon carcinoma participating in NCCTG and NSABP adjuvant chemotherapy trials

肥胖与DNA错配修复状态及参与NCCTG和NSABP辅助化疗试验的II期或III期结肠癌患者的临床结局之间的关联

期刊:Journal of Clinical Oncology

影响因子:41.9

doi:10.1200/JCO.2011.39.2563

Sinicrope, Frank A; Foster, Nathan R; Yoon, Harry H; Smyrk, Thomas C; Kim, George P; Allegra, Carmen J; Yothers, Greg; Nikcevich, Daniel A; Sargent, Daniel J

North central cancer treatment group (NCCTG) N0537: phase II trial of VEGF-trap in patients with metastatic breast cancer previously treated with an anthracycline and/or a taxane

北中部癌症治疗协作组 (NCCTG) N0537：VEGF-trap 在既往接受过蒽环类和/或紫杉烷类药物治疗的转移性乳腺癌患者中的 II 期试验

期刊:Clinical Breast Cancer

影响因子:2.5

doi:10.1016/j.clbc.2012.09.007

Sideras, Kostandinos; Dueck, Amylou C; Hobday, Timothy J; Rowland, Kendrith M Jr; Allred, Jacob B; Northfelt, Donald W; Lingle, Wilma L; Behrens, Robert J; Fitch, Tom R; Nikcevich, Daniel A; Perez, Edith A

Online Intervention for Muscle Tension Dysphonia: A Pilot Randomized Clinical Trial

针对肌肉紧张性发声障碍的在线干预：一项试点随机临床试验

Improving Rural Clinical Trial Enrollment: Recommendations From the Rural Health Working Group of the Alliance Clinical Trials Network

改善农村临床试验入组率：联盟临床试验网络农村卫生工作组的建议

Induction versus no induction chemotherapy before neoadjuvant chemoradiotherapy and surgery in oesophageal adenocarcinoma: a multicentre randomised phase II trial (NCCTG N0849 [Alliance])

食管腺癌新辅助放化疗和手术前是否进行诱导化疗：一项多中心随机 II 期试验 (NCCTG N0849 [Alliance])

Patient-reported predictors of early treatment discontinuation: treatment-related symptoms and health-related quality of life among postmenopausal women with primary breast cancer randomized to anastrozole or exemestane on NCIC Clinical Trials Group (CCTG) MA.27 (E1Z03)

患者报告的早期治疗中断预测因素：在 NCIC 临床试验组 (CCTG) MA.27 (E1Z03) 中随机分配接受阿那曲唑或依西美坦治疗的绝经后原发性乳腺癌女性的治疗相关症状和健康相关生活质量

Akt inhibitor MK-2206 in combination with bendamustine and rituximab in relapsed or refractory chronic lymphocytic leukemia: Results from the N1087 alliance study

Akt抑制剂MK-2206联合苯达莫司汀和利妥昔单抗治疗复发或难治性慢性淋巴细胞白血病：N1087联盟研究结果

A randomized phase II trial comparing chemoimmunotherapy with or without bevacizumab in previously untreated patients with chronic lymphocytic leukemia.

一项随机 II 期试验比较了化疗免疫疗法联合或不联合贝伐单抗治疗既往未接受治疗的慢性淋巴细胞白血病患者的疗效

The use of Ginkgo biloba for the prevention of chemotherapy-related cognitive dysfunction in women receiving adjuvant treatment for breast cancer, N00C9

银杏叶提取物用于预防接受乳腺癌辅助治疗的女性化疗相关认知功能障碍的研究，N00C9

A Phase II trial of docetaxel and carboplatin administered every 2 weeks as preoperative therapy for stage II or III breast cancer: NCCTG study N0338

多西他赛和卡铂每两周给药一次，作为 II 期或 III 期乳腺癌术前治疗的 II 期试验：NCCTG 研究 N0338

Association of obesity with DNA mismatch repair status and clinical outcome in patients with stage II or III colon carcinoma participating in NCCTG and NSABP adjuvant chemotherapy trials

肥胖与DNA错配修复状态及参与NCCTG和NSABP辅助化疗试验的II期或III期结肠癌患者的临床结局之间的关联

North central cancer treatment group (NCCTG) N0537: phase II trial of VEGF-trap in patients with metastatic breast cancer previously treated with an anthracycline and/or a taxane

北中部癌症治疗协作组 (NCCTG) N0537：VEGF-trap 在既往接受过蒽环类和/或紫杉烷类药物治疗的转移性乳腺癌患者中的 II 期试验